Assessment of Stroke Volume in Shock Using Echocardiography Versus Bioreactive Impedance

Part of paid clinical trials in Las Vegas, Nevada.

Sponsor
University of Nevada, Las Vegas
Study ID
NCT07020637
Status
Recruiting
Apply to this trial

Conditions

  • Critical Illness
  • Shock

Eligibility Criteria

Sex
ALL
Age
18 Years - 90 Years
Healthy Volunteers
Not accepted

Interventions

  • Cheetah NICOM — DEVICE
    Bioreactance-based noninvasive cardiac output monitoring device used to measure stroke volume before and after passive leg raising. Used solely for observational measurement. No therapeutic intervention is performed.

Study Details

This study aims to evaluate the correlation between stroke volume measurements obtained by transthoracic echocardiography and bioreactance-based noninvasive cardiac output monitoring. The primary objective is to assess the level of agreement between these two modalities in critically ill patients.

Key Dates

Start date
Oct 19, 2024
Status verified
Apr 2026
Primary completion
Apr 30, 2026
Completion
Apr 30, 2026

Study Design

Enrollment
30 participants (estimated)

Arms

  • Arm: Shock Patients
    This cohort includes adult patients presenting with clinical signs of shock in the intensive care unit. Each participant will undergo stroke volume measurement using both transthoracic echocardiography and bioreactance-based monitoring (Cheetah NICOM) before and after passive leg raising. No therapeutic intervention will be performed as part of the study.

Primary Outcome Measure

Correlation Between Stroke Volume Measurements by Echocardiography and Bioreactance Monitoring [ Time Frame: Within 1 hour of enrollment ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University Medical Center Southern NevadaLas VegasNevada89102
Mutsumi J Kioka, Medical Doctor
[email protected]
7026712345

Find similar trials in Las Vegas, NV

By research site
University Medical Center Southern Nevada· Las Vegas, NV

Related Studies